12 HR bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG Extended Release Oral Tablet [Contrave]
RxNorm concept 1551474, branded drug (sbd). Prescribable name: Contrave 8 MG / 90 MG 12HR Extended Release Oral Tablet.
- RxCUI
- 1551474
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1551474 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
12 HR buPROPion hydrochloride 90 MG / naltrexone hydrochloride 8 MG Extended Release Oral Tablet [Contrave]; Contrave (buPROPion hydrochloride 90 MG / naltrexone hydrochloride 8 MG) 12 HR Extended Release Oral Tablet; Contrave (bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG) 12 HR Extended Release Oral Tablet
Related concepts
- bupropion hydrochloride 90 MG (SCDC, consists of)
- naltrexone hydrochloride 8 MG (SCDC, consists of)
- bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG [Contrave] (SBDC, consists of)
- Extended Release Oral Tablet (DF, has dose form)
- Contrave (BN, has ingredient)
- 12 HR bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG Extended Release Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 43063077270
- 50090294500
- 51267089007
- 51267089099
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1551474 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1551474 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1551474. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.